Brief: Nautilus Biotechnology Partners With The Translational Genomics Research Institute (Tgen) To Investigate Applications Of Single-Molecule Proteomic Analysis In Diffuse Intrinsic Pontine Glioma (Dipg)
19/01/2023 13:05
Jan 19 (Reuters) - Nautilus Biotechnology Inc NAUT.O :
* NAUTILUS BIOTECHNOLOGY PARTNERS WITH THE TRANSLATIONAL
GENOMICS
RESEARCH INSTITUTE (TGEN) TO INVESTIGATE APPLICATIONS OF
SINGLE-MOLECULE PROTEOMIC ANALYSIS IN DIFFUSE INTRINSIC PONTINE
GLIOMA (DIPG)
* NAUTILUS BIOTECHNOLOGY INC - PARTNERSHIP WILL COMMENCE IN
EARLY
2023 AND TEAM INTENDS TO PUBLISH ITS FINDINGS ONCE STUDY IS
COMPLETED
Source text for Eikon: ID:nGNX8kNvMY
Further company coverage: NAUT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nautilus Biotechnology
See all newsNautilus Biotechnology, Inc. expected to post a loss of 14 cents a share - Earnings Preview
Brief: Nautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing
Nautilus Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Nautilus Biotechnology posts first revenue, Q2 net loss narrows
Brief: Nautilus Biotechnology Q2 EPS USD -0.11